F-star Biotechnology Competitors and Similar CompaniesClear all
KemPharm's competitors and similar companies include Aceragen.
 KemPharm KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. |  Aceragen Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates. | |
Founding Date | Founding Date 2006 | Founding Date 1989 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Kissimmee, US HQ Blacksburg, US Coralville, US Coralville, US | Locations Durham, US HQ |
Employees | Employees 333% increase | Employees 3642% decrease |
Valuation ($) | Valuation ($) 200.5 m | Valuation ($) 3.2 m |
Financial | ||
Revenue (est.) | Revenue (est.) $106.5m (FY, 2025) | Revenue (est.) $4.9m (FY, 2022) |
Net income | Net income $83.2m (FY, 2025) | Net income ($23.4m) (FY, 2022) |
For sources of this data, please see the company profile
View Company Profiles
Aceragen
HQ
Durham, US
Employees
36↓ 42% decrease
Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
View company